Arrowstreet Capital’s PetMed Express PETS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $289K | Sell |
126,774
-48,459
| -28% | -$141K | ﹤0.01% | 1736 |
|
|
2025
Q4 | $561K | Hold |
175,233
| – | – | ﹤0.01% | 1660 |
|
|
2025
Q3 | $440K | Sell |
175,233
-71,197
| -29% | -$220K | ﹤0.01% | 1718 |
|
|
2025
Q2 | $818K | Sell |
246,430
-7,199
| -3% | -$25.6K | ﹤0.01% | 1656 |
|
|
2025
Q1 | $1.06M | Sell |
253,629
-259,752
| -51% | -$1.18M | ﹤0.01% | 1459 |
|
|
2024
Q4 | $2.47M | Buy |
513,381
+107,614
| +27% | +$504K | ﹤0.01% | 1219 |
|
|
2024
Q3 | $1.49M | Sell |
405,767
-12,991
| -3% | -$46K | ﹤0.01% | 1297 |
|
|
2024
Q2 | $1.7M | Sell |
418,758
-145,135
| -26% | -$620K | ﹤0.01% | 1115 |
|
|
2024
Q1 | $2.7M | Buy |
563,893
+18,612
| +3% | +$108K | ﹤0.01% | 1059 |
|
|
2023
Q4 | $4.12M | Buy |
+545,281
| New | +$4.48M | ﹤0.01% | 806 |
|
|
2023
Q3 | – | Sell |
-117,983
| Closed | -$1.63M | – | 1380 |
|
|
2023
Q2 | $1.63M | Buy |
+117,983
| New | +$1.77M | ﹤0.01% | 882 |
|
|
2022
Q3 | – | Sell |
-35,388
| Closed | -$704K | – | 1419 |
|
|
2022
Q2 | $704K | Buy |
+35,388
| New | +$791K | ﹤0.01% | 1017 |
|
|
2021
Q1 | – | Sell |
-92,458
| Closed | -$2.96M | – | 2461 |
|
|
2020
Q4 | $2.96M | Sell |
92,458
-261,161
| -74% | -$8.05M | ﹤0.01% | 1443 |
|
|
2020
Q3 | $11.2M | Sell |
353,619
-102,621
| -22% | -$3.4M | 0.02% | 784 |
|
|
2020
Q2 | $16.3M | Sell |
456,240
-149,518
| -25% | -$5.19M | 0.03% | 588 |
|
|
2020
Q1 | $17.4M | Sell |
605,758
-53,151
| -8% | -$1.39M | 0.05% | 327 |
|
|
2019
Q4 | $15.5M | Buy |
658,909
+602,935
| +1,077% | +$13.5M | 0.04% | 469 |
|
|
2019
Q3 | $1.01M | Buy |
55,974
+45,874
| +454% | +$758K | ﹤0.01% | 1162 |
|
|
2019
Q2 | $158K | Buy |
+10,100
| New | +$199K | ﹤0.01% | 1320 |
|
|
2018
Q3 | – | Sell |
-321,689
| Closed | -$14.2M | – | 1214 |
|
|
2018
Q2 | $14.2M | Sell |
321,689
-691,845
| -68% | -$26.8M | 0.03% | 354 |
|
|
2018
Q1 | $42.3M | Hold |
1,013,534
| – | – | 0.1% | 209 |
|
|
2017
Q4 | $46.1M | Hold |
1,013,534
| – | – | 0.11% | 190 |
|
|
2017
Q3 | $33.6M | Buy |
1,013,534
+986,666
| +3,672% | +$40.2M | 0.09% | 206 |
|
|
2017
Q2 | $1.09M | Buy |
+26,868
| New | +$833K | ﹤0.01% | 764 |
|
|
2015
Q3 | – | Sell |
-24,800
| Closed | -$428K | – | 1459 |
|
|
2015
Q2 | $428K | Buy |
+24,800
| New | +$416K | ﹤0.01% | 1006 |
|
|
2015
Q1 | – | Sell |
-10,902
| Closed | -$157K | – | 1172 |
|
|
2014
Q4 | $157K | Buy |
+10,902
| New | +$147K | ﹤0.01% | 1192 |
|
|
2014
Q1 | – | Sell |
-69,655
| Closed | -$1.16M | – | 1289 |
|
|
2013
Q4 | $1.16M | Buy |
69,655
+15,979
| +30% | +$250K | 0.01% | 798 |
|
|
2013
Q3 | $874K | Buy |
53,676
+46,763
| +676% | +$729K | 0.01% | 699 |
|
|
2013
Q2 | $87K | Buy |
+6,913
| New | +$90.1K | ﹤0.01% | 782 |
|
Other funds holding PETS
VCM
SPH
FAM
Arrowstreet Capital's PETS Position: Q1 2026 in Review
Arrowstreet Capital reduced its PetMed Express (PETS) stake by 28% in Q1 2026, selling an estimated $141K and leaving 126,774 shares worth $289K. The position accounts for ﹤0.01% of the portfolio, ranked #1736.
Arrowstreet Capital first reported a position in PETS in Q2 2013 and has held it in 29 quarters since. The position peaked at $46.1M in Q4 2017. 49 funds tracked by Wall St. Rank hold PETS as of Q1 2026.
- Arrowstreet Capital held 126,774 shares of PetMed Express worth $289K as of Q1 2026.
- Arrowstreet Capital sold 48,459 PetMed Express shares in Q1 2026, an estimated $141K.
- PetMed Express made up ﹤0.01% of Arrowstreet Capital's portfolio in Q1 2026, its #1736 holding.
- Arrowstreet Capital first reported a position in PetMed Express in Q2 2013 and has held it in 29 quarters since.
- Arrowstreet Capital's PetMed Express position peaked at $46.1M in Q4 2017.
- 49 funds tracked by Wall St. Rank held PetMed Express as of Q1 2026.
Based on Arrowstreet Capital's 13F filing for Q1 2026, filed 14 May 2026.